Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

36.05
-0.3900-1.07%
Post-market: 36.900.8500+2.36%19:30 EDT
Volume:5.78M
Turnover:207.97M
Market Cap:42.00B
PE:60.08
High:36.33
Open:36.17
Low:35.62
Close:36.44
52wk High:38.37
52wk Low:18.14
Shares:1.17B
Float Shares:1.09B
Volume Ratio:1.36
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.42
PE(LYR):29.79

Loading ...

Stocks to Watch: Sono Group, Teva Pharmaceuticals, Pyxis Tankers, Metallus

Dow Jones
·
8 hours ago

Teva to lower cost of select medicines for American patients covered by Medicaid

TIPRANKS
·
11 hours ago

Etsy, ConocoPhillips, Intuit, Teva, Rithm: Insider Cashouts

TIPRANKS
·
Aug 29

BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals

GlobeNewswire
·
Aug 28

Piper Sandler Keeps Their Buy Rating on Teva Pharmaceutical (TEVA)

TIPRANKS
·
Aug 27

Teva Pharmaceutical Rocked by Eye-Catching Insider Stock Moves

TIPRANKS
·
Aug 26

Teva Pharmaceutical Industries (TEVA) Could Be 10% Undervalued After FDA Accepted Ecopipam NDA

Simply Wall St.
·
Aug 25

Teva (TEVA) Wins FDA Priority Review For Pediatric Tourette Drug Candidate

Simply Wall St.
·
Aug 20

TEVA Stock Climbs as 50-Year-Long Tourette Syndrome Drug Breakthrough Moves Closer

TIPRANKS
·
Aug 19

Teva Pharmaceuticals Says FDA Accepts Ecopipam Filing for Tourette Syndrome

MT Newswires Live
·
Aug 19

Teva price target raised to $42 from $40 at Barclays

TIPRANKS
·
Aug 17

Teva Pharmaceuticals Price Target Raised to $42.00/Share from $40.00 by Barclays

Dow Jones
·
Aug 12

Teva Seeks to Keep Israel Ties from Jury, Cites Gaza War

Reuters
·
Aug 07

July 2026's Top Stock Selections Estimated Below Intrinsic Value

Simply Wall St.
·
Jul 31

Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST), Teva Pharmaceutical (TEVA) and MannKind (MNKD)

TIPRANKS
·
Jul 30

Stocks to Watch Recap: Ford, Caterpillar, Teva, Starbucks

Dow Jones
·
Jul 30

Teva's Innovative Drug Portfolio Fuels Growth as Company Raises Outlook, Transitions to Direct NYSE Listing

Benzinga Earnings
·
Jul 30

Movement Alert|Teva Pharmaceutical Rises 6.95% in Regular Trading, Q2 Revenue Beats Expectations and Full-Year Guidance Raised

Market Focus
·
Jul 29

Stock Track | Teva Pharmaceutical Soars 6.47% Intraday on Q2 Revenue Beat and Raised Sales Outlook

Stock Track
·
Jul 29

Teva Pharmaceutical Industries Q2 Adjusted Earnings, Revenue Fall; Raises 2026 Revenue Guidance

MT Newswires Live
·
Jul 29